Compare Mounjaro vs Wegovy Pricing with Exclusive Codes
Mounjaro vs Wegovy Weight Loss: Understanding Your Discount Options
When comparing Mounjaro vs Wegovy for weight loss, the pricing structure becomes a crucial factor in your decision-making process. EverydayMeds simplifies this comparison by offering both treatments with identical discount codes—FIRST40 for new customers and DOSE25 for returning customers, both applied at checkout to reach our listed prices. This transparent approach means you can focus on the clinical differences between these prescription-only medicines rather than navigating complex pricing structures.
The key distinction lies in their mechanisms: Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. Both treatments require dose escalation and must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber can help determine which mechanism aligns best with your medical history and weight management goals during the clinical assessment process.
Wegovy Pricing Structure with Applied Discount Codes
Our Wegovy pricing reflects the discount codes already applied, starting with the 0.25mg starter dose at £79.99 for weeks 1-4 of treatment. The dose escalation continues with 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and the maintenance 2.4mg dose at £209.99 for week 17 onwards. These prices represent the final cost after applying either FIRST40 or DOSE25 discount codes at checkout.
Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg & 1mg) at £299.99 for your first three months, or the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99. For maintenance therapy, the Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring consistent supply without frequent reordering. All bundles are designed for convenience and Reliable Supply rather than per-pen savings, with the same discount codes applicable at checkout.
Clinical Evidence: Mounjaro vs Wegovy Weight Loss Trials
The STEP trial programme demonstrated Wegovy's efficacy, with participants achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of approximately 15.2% at two years, while the SELECT cardiovascular outcomes trial reported a 20% reduction in major adverse cardiovascular events.
Mounjaro's SURMOUNT trials evaluated tirzepatide for weight management, though direct comparison with STEP trial results isn't appropriate due to different study designs, populations, and endpoints. Both medications have undergone rigorous clinical testing, and your prescriber will consider your individual circumstances when recommending between these prescription-only medicines during the clinical assessment process.
How Wegovy Works in Mounjaro vs Wegovy Weight Loss Comparison
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural hormone that regulates appetite and food intake. When injected once weekly using the FlexTouch pen system, semaglutide binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing food cravings. This mechanism helps patients feel satisfied with smaller portions during meals, supporting adherence to reduced-calorie dietary plans. The treatment works gradually as doses escalate from 0.25mg to the maintenance 2.4mg dose over 16 weeks, allowing your body to adjust to each increment. Unlike Mounjaro's dual receptor approach, Wegovy specifically targets GLP-1 pathways, which may suit patients who respond well to this single-mechanism approach.
Streamlined Ordering Process for Both Treatments
EverydayMeds has standardised the ordering process whether you choose Wegovy or Mounjaro after comparing these weight loss treatments. The journey begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring appropriate prescribing for either treatment option. Once approved, your prescription-only medicine is dispatched via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C temperature throughout transit. This temperature-controlled system protects the medication's efficacy whether you're receiving Wegovy's semaglutide or Mounjaro's tirzepatide formulation. All orders include comprehensive injection guidance and ongoing clinical support from our GPhC-registered pharmacy team (#9012878).
Storage and Practical Considerations: Mounjaro vs Wegovy Weight Loss Management
Storage requirements represent a practical advantage when comparing Mounjaro vs Wegovy for weight loss management. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability (below 30°C) compared to Mounjaro's 21-day limit once removed from the fridge. The Wegovy FlexTouch pen system provides precise dose delivery with clear dosing windows and audible injection completion clicks, supporting consistent weekly administration. Dose escalation cannot be skipped for either treatment, making adherence to the prescribed schedule essential for optimal results. Both medications are administered via subcutaneous injection in the thigh, abdomen, or upper arm, with injection site rotation recommended to prevent lipodystrophy. The weekly injection timing can be adjusted by up to 2 days if necessary, providing flexibility for travel or schedule changes while maintaining therapeutic consistency.
Discount Code Strategy: Maximising Value in Mounjaro vs Wegovy Weight Loss Treatment
Understanding how to apply discount codes effectively can significantly impact your treatment costs when comparing Mounjaro vs Wegovy for weight loss. New patients should use code FIRST40 at checkout, while returning customers benefit from DOSE25—both codes are applied during the final purchase step to reach our published prices. The codes work identically for both Wegovy and Mounjaro, ensuring fair pricing regardless of which treatment your prescriber recommends after clinical assessment.
Planning your treatment progression helps maximise discount benefits across multiple orders. Consider bundling complementary doses like our Intro Duo (0.25mg & 0.5mg) at £169.99 rather than separate purchases, especially when factoring in delivery costs and supply continuity. The discount codes apply to all bundle configurations, making longer-term planning financially advantageous while ensuring uninterrupted treatment progression through the mandatory dose escalation phases.
Making Your Final Decision with Expert Support
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your individual circumstances and weight management objectives. The clinical assessment process evaluates factors including your medical history, concurrent medications, previous weight loss attempts, and lifestyle considerations to guide this important decision. Whether you proceed with Wegovy's established GLP-1 approach or Mounjaro's innovative dual-receptor mechanism, our GPhC-registered pharmacy (#9012878) ensures consistent supply and ongoing clinical support. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, and remember to apply discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing. Start your weight management journey with confidence, knowing you're receiving genuine prescription-only medicines backed by comprehensive pharmaceutical care and expert clinical guidance.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
